Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.57EUR
−100.17 MEUR
115.10 MEUR
139.45 M
About Heron Therapeutics, Inc.
Sector
Industry
CEO
Craig A. Collard
Website
Headquarters
San Diego
Employees (FY)
126
Founded
1983
FIGI
BBG000FJTSF2
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AXD2 is 2.65 EUR — it has decreased by 19.67% in the past 24 hours. Watch HERON THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HERON THERAPEUTICS INC stocks are traded under the ticker AXD2.
AXD2 stock has fallen by 11.39% compared to the previous week, the month change is a 16.05% fall, over the last year HERON THERAPEUTICS INC has showed a 147.29% increase.
We've gathered analysts' opinions on HERON THERAPEUTICS INC future price: according to them, AXD2 price has a max estimate of 8.36 EUR and a min estimate of 4.64 EUR. Watch AXD2 chart and read a more detailed HERON THERAPEUTICS INC stock forecast: see what analysts think of HERON THERAPEUTICS INC and suggest that you do with its stocks.
AXD2 reached its all-time high on Sep 9, 2015 with the price of 37.23 EUR, and its all-time low was 0.50 EUR and was reached on Nov 14, 2023. View more price dynamics on AXD2 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AXD2 stock is 24.49% volatile and has beta coefficient of 2.91. Track HERON THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is HERON THERAPEUTICS INC there?
Today HERON THERAPEUTICS INC has the market capitalization of 486.76 M, it has increased by 1.44% over the last week.
Yes, you can track HERON THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
HERON THERAPEUTICS INC is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
AXD2 earnings for the last quarter are −0.02 EUR per share, whereas the estimation was −0.07 EUR resulting in a 73.16% surprise. The estimated earnings for the next quarter are −0.04 EUR per share. See more details about HERON THERAPEUTICS INC earnings.
HERON THERAPEUTICS INC revenue for the last quarter amounts to 32.13 M EUR, despite the estimated figure of 30.56 M EUR. In the next quarter, revenue is expected to reach 33.69 M EUR.
AXD2 net income for the last quarter is −2.93 M EUR, while the quarter before that showed −9.72 M EUR of net income which accounts for 69.86% change. Track more HERON THERAPEUTICS INC financial stats to get the full picture.
No, AXD2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 3, 2024, the company has 126.00 employees. See our rating of the largest employees — is HERON THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HERON THERAPEUTICS INC EBITDA is −73.66 M EUR, and current EBITDA margin is −84.79%. See more stats in HERON THERAPEUTICS INC financial statements.
Like other stocks, AXD2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HERON THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HERON THERAPEUTICS INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HERON THERAPEUTICS INC stock shows the sell signal. See more of HERON THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.